Viewing Study NCT05468892


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2025-12-26 @ 6:35 AM
Study NCT ID: NCT05468892
Status: COMPLETED
Last Update Posted: 2024-02-01
First Post: 2022-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial
Sponsor: University of Campania Luigi Vanvitelli
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module